Back
Immunovant, Inc. Vs. Perspective Therapeutics, Inc. Industry Stock Comparison
Sell
30
IMVT
Immunovant, Inc.
Last Price:
$25.42
Seasonality Move:
-30.75%
Sell
50
CATX
Perspective Therapeutics, Inc.
Last Price:
$2.7500
Seasonality Move:
28.22%
Sell
30
Immunovant, Inc. (IMVT)
is a Sell
Is Immunovant, Inc. a Buy, Sell or Hold?
-
The current Immunovant, Inc. [IMVT] share price is $25.35. The Score for IMVT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
IMVT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Perspective Therapeutics, Inc. (CATX)
is a Sell
Is Perspective Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Perspective Therapeutics, Inc. [CATX] share price is $2.7400. The Score for CATX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IMVT Stock Price Chart
What is Immunovant, Inc.'s stock price today?
-
The Immunovant, Inc. share price today is $25.35The current trend is moderately bullish and IMVT is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics, Inc.'s stock price today?
-
The Perspective Therapeutics, Inc. share price today is $2.7400The current trend is moderately bullish and CATX is experiencing slight buying pressure.
IMVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.91 | Buy |
| Relative Strength Index (14 RSI): | 52.94 | Buy |
| Chaikin Money Flow: | 260846 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.09 - 26.49) | Buy |
| Bollinger Bands (100): | (15.57 - 23.95) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 54.1 | Buy |
| Chaikin Money Flow: | 195356 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.2404 - 2.7604) | Buy |
| Bollinger Bands (100): | (2.3965 - 3.7765) | Sell |
IMVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.4 | Sell |
| 20-day SMA: | 25.1 | Buy |
| 50-day SMA: | 23.62 | Buy |
| 200-day SMA: | 17.91 | Buy |
| 8-day EMA: | 26.03 | Sell |
| 20-day EMA: | 25.37 | Sell |
| 50-day EMA: | 23.41 | Buy |
| 200-day EMA: | 20.47 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.75 | Sell |
| 20-day SMA: | 2.57 | Buy |
| 50-day SMA: | 2.55 | Buy |
| 200-day SMA: | 3.02 | Sell |
| 8-day EMA: | 2.74 | Sell |
| 20-day EMA: | 2.64 | Buy |
| 50-day EMA: | 2.71 | Buy |
| 200-day EMA: | 3.57 | Sell |
Immunovant, Inc. Earnings Growth & IMVT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.07 per share.
Perspective Therapeutics, Inc. Earnings Growth & CATX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.17 per share.
Immunovant, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||